Evidence map›Paper›PMID 34959284›Full record

ArticlePharmaceutics2021

The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.

Adrian Rump, Franziska N Weiss, Louisa Schulz, Marie-Luise Kromrey, Eberhard Scheuch, Mladen V Tzvetkov, Tyler White, Shane Durkee, Kevin W Judge, Vincent Jannin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Adrian RumpDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.
Franziska N WeissDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.
Louisa SchulzDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.
Marie-Luise KromreyDepartment of Diagnostic Radiology and Neuroradiology, University Hospital Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-0420-7303
Eberhard ScheuchDepartment of Clinical Pharmacology, University Hospital Greifswald, 17487 Greifswald, Germany.
Mladen V TzvetkovDepartment of Clinical Pharmacology, University Hospital Greifswald, 17487 Greifswald, Germany.
Tyler WhiteLonza Capsules & Health Ingredients, Morristown, NJ 07960, USA.
Shane DurkeeLonza Capsules & Health Ingredients, Morristown, NJ 07960, USA.ORCID 0000-0003-0162-5865
Kevin W JudgeLonza Capsules & Health Ingredients, Morristown, NJ 07960, USA.
Vincent JanninLonza Capsules & Health Ingredients, 68000 Colmar, France.ORCID 0000-0003-1630-2807
Aouatef BellamineLonza Capsules & Health Ingredients, Morristown, NJ 07960, USA.ORCID 0000-0003-1894-2939
Werner WeitschiesDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0003-3492-7747
Michael GrimmDepartment of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-1310-7435
Universität Greifswald · DELonza (United States) · USUniversitätsmedizin Greifswald · DE

Funding

Lonza Capsules & Health Ingredients (Morristown, NJ, USA) n.a.
6 · The paper itself

Abstract

Controlling the time point and site of the release of active ingredients within the gastrointestinal tract after administration of oral delivery systems is still a challenge. In this study, the effect of the combination of small capsules (size 3) and large capsules (size 00) on the disintegration site and time was investigated using magnetic resonance imaging (MRI) in combination with a salivary tracer technique. As capsule shells, Vcaps

Indexed as

capsule-in-capsuleDUOCAP®HPMCin vivo disintegrationMRIsalivary tracersite-specific drug delivery

Identifiers

PMID34959284
PMCPMC8707024
OpenAlexW3214878112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.